The globalchemiluminescence immunoassay marketis expected to reach USD 10.67 billion by 2027, according to a new study by Polaris Market Research. The reportChemiluminescence Immunoassay Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments {Automated and Semi-automated}, Consumables, Software & Services); By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease); By End Use; By Regions; Segment Forecast, 2020 – 2027gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global chemiluminescence immunoassay market is driven by few notable factors such as rapid surge in the COVID- 19 cases, the awareness among the people about timely medical attention, and rapidly improving healthcare infrastructure in terms of rapid testing, which in turn, boosting the chemiluminescence immunoassay industry growth. Chemiluminescence immunoassay solutions are also used for detection of numerous severe diseases including autoimmune disease, cancer, and diabetes, among others.
The global chemiluminescence immunoassay industry is segmented on the basis of product, application, end-use, and region. In terms of product, the market is segmented into instruments, consumables, and software and services. Based on application, the market is classified as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease, autoimmune disease, and others. The end-use segment is further divided into hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and others.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link://m.nkkjrh.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-sample
年代egment Highlights
- The consumables segment of chemiluminescence immunoassay industry accounted for the largest revenue share in 2019 and is expected to continue its dominance over the forecast period. This can be attributed to the increasing demand for stains or reagents in therapeutics such as endocrinology and drug monitoring.
- Based on application, the infectious diseases segment is projected to constitute almost half of the market by the end of 2027 on account of the aggressive use of chemiluminescence immunoassay solutions in the healthcare industry to check pandemic infection in across the regions.
- Hospitals segment is expected to account for the largest revenue share by the end of 2027 on account of the increasing footfall in hospitals for the treatment of several infectious diseases and chronic diseases such as cancer driving chemiluminescence immunoassay solutions
List of Key Players
- DiaSorin S.p.A.
- Hoffmann-La Roche AG
- Abbott Laboratories
- Immunodiagnostic系统
- Maccura Biotechnology
- 年代henzhen Mindray
- Beckman Coulter Inc.
- Others
Polaris Market Research has segmented thechemiluminescence immunoassay marketreport on the basis of product, application, end-use, and region.
Chemiluminescence Immunoassay, Product Outlook (Revenue – USD Million, 2016 – 2027)
- Instruments
- Automated
- 年代emi-automated
- Consumables
- 年代oftware & Services
Chemiluminescence Immunoassay, Application Outlook (Revenue – USD Million, 2016 – 2027)
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease
- Autoimmune Disease
- Others
Chemiluminescence Immunoassay, End Use Outlook (Revenue – USD Million, 2016 – 2027)
- Hospitals
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
Chemiluminescence Immunoassay, Regional Outlook (Revenue – USD Million, 2016 – 2027)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- 年代pain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- 年代outh Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- 年代audi Arabia
- Israel
- 年代outh Africa